Wayne Pisano

Sanofi-Aventis has named Olivier Charmeil as its new senior VP of vaccines. Charmeil previously covered the Asia-Pacific and Japan regions in the company's pharmaceutical division, which Sanofi CEO

Sanofi-Aventis saw its net profit surge in the fourth quarter of 2009 as sales of the H1N1 vaccine hit 465 million euros (roughly $638.3 million). And Wayne Pisano, who helms the company's vaccines

Sanofi-Aventis closes on its deal to buy Acambis today, but it's working hard to avoid losing the entrepreneurial spirit that attracted the French pharma company to the vaccine developer in the first

The growing wealth seen in developing nations is spurring a big increase in the worldwide demand for vaccines, and Sanofi-Aventis says it will invest more than $6 billion over the next eight years in